glp 1 fda Says to Drop Suicide Warning From GLP-1 Drug Labels In a major milestone for
Description
3 Months $1200
Exploring the emerging research on GLP-1 receptor agonists and Parkinson's disease: understand the science, clinical trials, potential benefits, risks, and why these diabetes medications are being investigated for neuroprotection.
The approval pertains to the GLP-1 drug dubbed Xianweiying also known as ecnoglutide which Pfizer has just acquired in a billion-dollar deal.
Their potential for disease modification and symptom relief, particularly in specific phenotypes, supports their further exploration as part of a personalized treatment approach.
